Terms: = Breast cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659 AND Treatment
7 results:
1. From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (Artemia).
Wood CR; Wu WT; Yang YS; Yang JS; Xi Y; Yang WJ
Adv Cancer Res; 2023; 158():199-231. PubMed ID: 36990533
[TBL] [Abstract] [Full Text] [Related]
2. Role of dek in carcinogenesis, diagnosis, prognosis, and therapeutic outcome of breast cancer: An evidence-based clinical review.
Habiburrahman M; Sutopo S; Wardoyo MP
Crit Rev Oncol Hematol; 2023 Jan; 181():103897. PubMed ID: 36535490
[TBL] [Abstract] [Full Text] [Related]
3. NMR-based metabolomic analysis identifies RON-dek-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival.
Vicente-Muñoz S; Hunt BG; Lange TE; Wells SI; Waltz SE
PLoS One; 2022; 17(9):e0274128. PubMed ID: 36067206
[TBL] [Abstract] [Full Text] [Related]
4. Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana.
Anwar T; Rufail ML; Djomehri SI; Gonzalez ME; Lazo de la Vega L; Tomlins SA; Newman LA; Kleer CG
Mod Pathol; 2020 Aug; 33(8):1537-1545. PubMed ID: 32152520
[TBL] [Abstract] [Full Text] [Related]
5. The unique dek oncoprotein in women's health: A potential novel biomarker.
de Albuquerque Oliveira AC; Kappes F; Martins DBG; de Lima Filho JL
Biomed Pharmacother; 2018 Oct; 106():142-148. PubMed ID: 29957464
[TBL] [Abstract] [Full Text] [Related]
6. Systematically defining single-gene determinants of response to neoadjuvant chemotherapy reveals specific biomarkers.
Witkiewicz AK; Balaji U; Knudsen ES
Clin Cancer Res; 2014 Sep; 20(18):4837-48. PubMed ID: 25047707
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study.
Gobardhan PD; Elias SG; Madsen EV; Bongers V; Ruitenberg HJ; Perre CI; van Dalen T
Ann Oncol; 2009 Jan; 20(1):41-8. PubMed ID: 18653702
[TBL] [Abstract] [Full Text] [Related]
